Circulation: Cardiovascular Interventions

APRIL 2, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Current therapy for in-stent restenosis (ISR) is based on drug-eluting stents (DES) or drug-eluting balloon catheters. mm), except in the post hoc subanalysis for the BMS-ISR group (0.203 mm [95% CI, 0.584 to 0.178]).

Stent 40

Stent Stents Myocardial Infarction Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

MARCH 30, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. Endpoints included major adverse cardiovascular events (MACE), cardiac death, myocardial infarction (MI), periprocedural MI, all-cause mortality, stent thrombosis (definite or probable), and target vessel revascularization (TVR).

Thrombosis 40

Thrombosis Myocardial Infarction Stent Stents 40

Circulation: Cardiovascular Interventions

FEBRUARY 20, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Patients with ST-segment–elevation myocardial infarction but no coronary microvascular injury are at low risk of early cardiovascular complications (ECC).

Myocardial Infarction 40

Myocardial Infarction STEMI Cardiogenic Shock Cardiac Arrest 40

Circulation: Cardiovascular Interventions

MARCH 17, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 3 , Page e014899, March 1, 2025. BACKGROUND:Ineligibility for surgical revascularization is increasingly prevalent and associated with increased mortality after percutaneous coronary intervention (PCI).

Coronary Artery Disease 40

Coronary Artery Disease Outcomes Myocardial Infarction Cardiovascular Interventions 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. INTRODUCTION:Percutaneous coronary intervention for complex coronary disease is associated with a high risk of cardiogenic shock. Cardiogenic shock and acute ST-segment–elevation myocardial infarction are exclusions.

Cardiogenic Shock 40

Cardiogenic Shock Myocardial Infarction Coronary Artery Disease Quality of Life 40

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. The primary end point was target vessel failure defined as a composite of cardiac death, target vessel–related myocardial infarction, or clinically driven target vessel revascularization.Results:At a median follow-up of 2.1 years (interquartile range 1.1

Myocardial Infarction 40

Myocardial Infarction Coronary Artery Disease Cardiovascular Interventions Outcomes 40

Circulation

NOVEMBER 11, 2024

Circulation, Volume 150, Issue Suppl_1 , Page A4142612-A4142612, November 12, 2024. Background:The CHIP score, developed from the BCIS (British Cardiovascular Intervention Society) database, predicts adverse in-hospital MACCE (major adverse cardiovascular and cerebrovascular events). 1.49; score 3-4: HR 1.95, 95% CI 1.62-2.35;

Myocardial Infarction 40

Myocardial Infarction Cardiovascular Interventions Strokes Stroke 40

Circulation: Cardiovascular Interventions

FEBRUARY 27, 2024

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:The American College of Cardiology Reduce the Risk: PCI Bleed Campaign was a hospital-based quality improvement campaign designed to reduce post-percutaneous coronary intervention (PCI) bleeding events.

Myocardial Infarction 45

Myocardial Infarction Hospital Cardiovascular Interventions Outcomes 45

Circulation: Cardiovascular Interventions

NOVEMBER 6, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. FFR-guided PCI was associated with the reduction of death and myocardial infarction in both patients with QCA stenosis ≥70% (6.7% There was no significant interaction between treatment strategy and non-IRA stenosis severity (p for interaction=0.636).

Myocardial Infarction 40

Myocardial Infarction Stenosis Cardiovascular Interventions Circulation 40

Circulation: Cardiovascular Interventions

NOVEMBER 28, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:There are limited data regarding the safety of deferral of percutaneous coronary intervention based on intravascular ultrasound (IVUS) findings.

Outcomes 40

Outcomes Myocardial Infarction Ultrasound Stenosis 40

Circulation: Cardiovascular Interventions

JANUARY 20, 2025

Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. Therefore, it is critically important to understand the validity of these claims-based end points.

Aortic valve 40

Aortic valve Outcomes Pacemaker Aortic 40

Circulation: Cardiovascular Interventions

OCTOBER 22, 2023

Circulation: Cardiovascular Interventions, Ahead of Print. Background:Atherosclerotic cardiovascular disease (ASCVD) is highly prevalent in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement (TAVR). Exposure of interest was PVD. Primary outcome was all-cause mortality.

Aortic valve 40

Aortic valve Aortic TAVR Outcomes 40

Circulation: Cardiovascular Interventions

JANUARY 15, 2024

Circulation: Cardiovascular Interventions, Volume 17, Issue 1 , Page e013006, January 1, 2024. BACKGROUND:We previously reported the use of minimal stent area to predict angiographic in-stent restenosis after drug-eluting stent implantation for unprotected left main (LM) disease. mm2for distal LM (area under the curve, 0.57;P=0.15),

Stent 40

Stent Stents Myocardial Infarction Stenosis 40

Dr. Smith's ECG Blog

AUGUST 3, 2017

Electrocardiographic Manifestations: Acute posterior wall myocardial infarction. Posterior myocardial infarction: the dark side of the moon. New electrocardiographic criteria for posterior wall myocardial ischemia validated by percutaneous transluminal coronary angioplasty model of acute myocardial infarction.

Chest Pain 52

Chest Pain Myocardial Infarction STEMI Ischemia 52

Circulation: Cardiovascular Interventions

MARCH 31, 2025

Circulation: Cardiovascular Interventions, Ahead of Print. BACKGROUND:Myocardial injury detected after percutaneous coronary intervention (PCI) is associated with increased mortality. Predictors of post-PCI myocardial injury are not well established.

Myocardial Infarction 40

Myocardial Infarction Anatomy Cardiovascular Interventions Heart Disease 40

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The Society (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Society of Thoracic Surgeons - Research

APRIL 20, 2023

Institutional Coronary Artery Bypass Case Volumes and Outcomes European Journal of Heart Failure October 2023 Makoto Mori 1 Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation The Annals of Thoracic Surgery August 2023 Carlos Diaz-Castrillion 2 Volume-Failure to Rescue Relationship in Acute Type A Aortic Dissections: An Analysis of The (..)

Research 52

Research Coronary Artery Bypass Graft Aortic valve Congenital 52

Dr. Smith's ECG Blog

MARCH 8, 2025

The authors describe a case with some features in common with our patient -- a stressful event followed by a stress cardiomyopathy/acute myocardial infarction overlap syndrome. Acute myocardial infarction: an uncommon complication of takotsubo cardiomyopathy. Circulation Research , 114 (12), 18521866. SanzRuiz, R.,

Cardiomyopathy 75

Cardiomyopathy Myocardial Infarction Defibrillator Bradycardia 75